310 related articles for article (PubMed ID: 29351794)
1. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
Gurka MJ; Guo Y; Filipp SL; DeBoer MD
Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
[TBL] [Abstract][Full Text] [Related]
2. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
DeBoer MD; Filipp SL; Gurka MJ
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
[TBL] [Abstract][Full Text] [Related]
3. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.
Malik S; Zhao Y; Budoff M; Nasir K; Blumenthal RS; Bertoni AG; Wong ND
JAMA Cardiol; 2017 Dec; 2(12):1332-1340. PubMed ID: 29117273
[TBL] [Abstract][Full Text] [Related]
4. Use of BMI as the marker of adiposity in a metabolic syndrome severity score: Derivation and validation in predicting long-term disease outcomes.
Gurka MJ; Filipp SL; Musani SK; Sims M; DeBoer MD
Metabolism; 2018 Jun; 83():68-74. PubMed ID: 29410278
[TBL] [Abstract][Full Text] [Related]
5. Childhood Age and Associations Between Childhood Metabolic Syndrome and Adult Risk for Metabolic Syndrome, Type 2 Diabetes Mellitus and Carotid Intima Media Thickness: The International Childhood Cardiovascular Cohort Consortium.
Koskinen J; Magnussen CG; Sinaiko A; Woo J; Urbina E; Jacobs DR; Steinberger J; Prineas R; Sabin MA; Burns T; Berenson G; Bazzano L; Venn A; Viikari JSA; Hutri-Kähönen N; Raitakari O; Dwyer T; Juonala M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862940
[TBL] [Abstract][Full Text] [Related]
6. The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.
Vishnu A; Gurka MJ; DeBoer MD
Atherosclerosis; 2015 Nov; 243(1):278-85. PubMed ID: 26409627
[TBL] [Abstract][Full Text] [Related]
7. Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
Gurka MJ; Filipp SL; Pearson TA; DeBoer MD
J Am Heart Assoc; 2018 Aug; 7(16):e009754. PubMed ID: 30369320
[TBL] [Abstract][Full Text] [Related]
8. Use of a Metabolic Syndrome Severity
DeBoer MD; Filipp SL; Gurka MJ
Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282
[TBL] [Abstract][Full Text] [Related]
9. Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease.
DeBoer MD; Gurka MJ; Morrison JA; Woo JG
Int J Obes (Lond); 2016 Sep; 40(9):1353-9. PubMed ID: 27133621
[TBL] [Abstract][Full Text] [Related]
10. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.
Gurka MJ; Lilly CL; Oliver MN; DeBoer MD
Metabolism; 2014 Feb; 63(2):218-25. PubMed ID: 24290837
[TBL] [Abstract][Full Text] [Related]
11. Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study.
Gurka MJ; Golden SH; Musani SK; Sims M; Vishnu A; Guo Y; Cardel M; Pearson TA; DeBoer MD
Diabetologia; 2017 Jul; 60(7):1261-1270. PubMed ID: 28378033
[TBL] [Abstract][Full Text] [Related]
12. Development of a metabolic syndrome severity score and its association with incident diabetes in an Asian population-results from a longitudinal cohort in Singapore.
Low S; Khoo KCJ; Wang J; Irwan B; Sum CF; Subramaniam T; Lim SC; Wong TKM
Endocrine; 2019 Jul; 65(1):73-80. PubMed ID: 31161560
[TBL] [Abstract][Full Text] [Related]
13. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
[TBL] [Abstract][Full Text] [Related]
14. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES).
Oye-Somefun A; Kuk JL; Ardern CI
BMC Cardiovasc Disord; 2021 Jul; 21(1):352. PubMed ID: 34311708
[TBL] [Abstract][Full Text] [Related]
15. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
Zhang Y; Hong J; Gu W; Gui M; Chen Y; Zhang Y; Chi Z; Wang W; Li X; Ning G
Endocrine; 2009 Oct; 36(2):233-8. PubMed ID: 19618299
[TBL] [Abstract][Full Text] [Related]
16. Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction.
Weinberg AE; Eisenberg M; Patel CJ; Chertow GM; Leppert JT
J Sex Med; 2013 Dec; 10(12):3102-9. PubMed ID: 24010555
[TBL] [Abstract][Full Text] [Related]
17. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
19. Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity.
DeBoer MD; Filipp SL; Sims M; Musani SK; Gurka MJ
Stroke; 2020 Aug; 51(8):2548-2552. PubMed ID: 32552367
[TBL] [Abstract][Full Text] [Related]
20. Exercise-induced albuminuria increases over time in individuals with impaired glucose metabolism.
Brzezinski RY; Friedensohn L; Shapira I; Zeltser D; Rogowski O; Berliner S; Grupper A; Shenhar-Tsarfaty S
Cardiovasc Diabetol; 2020 Jun; 19(1):90. PubMed ID: 32539802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
